Sign In

Login

Password

Forgot Password ? Sign Up

Sertralina (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sertralina" in Polish language version.

refsWebsite
Global rank Polish rank
10nih.gov
4th place
7th place
8doi.org
2nd place
6th place
3web.archive.org
1st place
1st place
1worldcat.org
5th place
2nd place
1windows.net
3,026th place
2,907th place
1psychcentral.com
9,619th place
2,030th place
1egis.pl
low place
low place
1csioz.gov.pl
low place
1,461st place

csioz.gov.pl

pub.rejestrymedyczne.csioz.gov.pl

doi.org

dx.doi.org

  • M.J. Owens i inni, Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites, „Journal of Pharmacology and Experimental Therapeutics”, 283 (3), 1997, s. 1305–1322, DOI: 10.2174/1871524910909030197, PMID: 9400006.
  • J.H. Meyer i inni, Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study, „The American Journal of Psychiatry”, 5, 161, 2004, s. 826–835, DOI: 10.1176/appi.ajp.161.5.826, PMID: 15121647.
  • Narita N.N. i inni, Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain, „European Journal of Pharmacology”, 307 (1), 1996, s. 117–119, DOI: 10.1016/0014-2999(96)00254-3, PMID: 8831113.
  • C. Gordon, R. Whale, P.J. Cowen, Sertraline treatment does not increase plasma prolactin levels in healthy subjects, „Psychopharmacology”, 137 (2), 1998, s. 201–202, DOI: 10.1007/s002130050610, PMID: 9630007.
  • R.S. Obach, L.M. Cox, L.M. Tremaine, Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study, „Drug Metab Dispos”, 33 (2), 2005, s. 262–270, DOI: 10.1124/dmd.104.002428, PMID: 15547048.
  • S.H. Preskorn i inni, Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers, „Journal of Clinical Psychopharmacology”, 27 (1), 2007, s. 28–34, DOI: 10.1097/00004714-200702000-00005, PMID: 17224709.
  • V. Ozdemir i inni, The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline, „Journal of Clinical Psychopharmacology”, 18 (1), 1998, s. 55–61, DOI: 10.1097/00004714-199802000-00009, PMID: 9472843.
  • C.L. Alfaro i inni, CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations, „J Clin Pharmacol”, 40 (1), 2000, s. 58–66, DOI: 10.1177/009127000004000108, PMID: 10631623.

egis.pl

nih.gov

ncbi.nlm.nih.gov

  • M.J. Owens i inni, Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites, „Journal of Pharmacology and Experimental Therapeutics”, 283 (3), 1997, s. 1305–1322, DOI: 10.2174/1871524910909030197, PMID: 9400006.
  • J.H. Meyer i inni, Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study, „The American Journal of Psychiatry”, 5, 161, 2004, s. 826–835, DOI: 10.1176/appi.ajp.161.5.826, PMID: 15121647.
  • J.M. Owens, D.L. Knight, C.B. Nemeroff, Inhibiteurs spécifiques de la recapture de la sérotonine (ISRS) de deuxième génération. Profil de liaison du transporteur de l’escitalopram et de la R-fluoxétine chez l’homme, „Encephale”, 28 (4), 2002, s. 350–355, PMID: 12232544 (fr.).
  • Narita N.N. i inni, Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain, „European Journal of Pharmacology”, 307 (1), 1996, s. 117–119, DOI: 10.1016/0014-2999(96)00254-3, PMID: 8831113.
  • K. Hashimoto, Sigma-1 Receptors and Selective Serotonin Reuptake Inhibitors: Clinical Implications of their Relationship, „Central Nervous System Agents in Medicinal Chemistry”, 2009, 2009, s. 197–204, PMID: 20021354.
  • C. Gordon, R. Whale, P.J. Cowen, Sertraline treatment does not increase plasma prolactin levels in healthy subjects, „Psychopharmacology”, 137 (2), 1998, s. 201–202, DOI: 10.1007/s002130050610, PMID: 9630007.
  • R.S. Obach, L.M. Cox, L.M. Tremaine, Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study, „Drug Metab Dispos”, 33 (2), 2005, s. 262–270, DOI: 10.1124/dmd.104.002428, PMID: 15547048.
  • S.H. Preskorn i inni, Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers, „Journal of Clinical Psychopharmacology”, 27 (1), 2007, s. 28–34, DOI: 10.1097/00004714-200702000-00005, PMID: 17224709.
  • V. Ozdemir i inni, The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline, „Journal of Clinical Psychopharmacology”, 18 (1), 1998, s. 55–61, DOI: 10.1097/00004714-199802000-00009, PMID: 9472843.
  • C.L. Alfaro i inni, CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations, „J Clin Pharmacol”, 40 (1), 2000, s. 58–66, DOI: 10.1177/009127000004000108, PMID: 10631623.

psychcentral.com

web.archive.org

windows.net

gdziepolek.blob.core.windows.net

worldcat.org